Phase II trial of the epothilone analog sagopilone (ZK219477; ZK EPO) in patients with recurrent glioblastoma: Initial report of the EORTC study 26061

Stupp, R. and Tosoni, A. and Taal, W. and Hau, P. and Campone, M. and Gijtenbeek, J. and Frenay, M. P. and Gorlia, T. and Lacombe, D. and Brandes, A. A. (2008) Phase II trial of the epothilone analog sagopilone (ZK219477; ZK EPO) in patients with recurrent glioblastoma: Initial report of the EORTC study 26061. JOURNAL OF CLINICAL ONCOLOGY, 26 (15supp): 2015. ISSN 0732-183X

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 14 Jan 2021 15:57
Last Modified: 14 Jan 2021 15:57
URI: https://pred.uni-regensburg.de/id/eprint/30897

Actions (login required)

View Item View Item